← Back to Patent Explorer
US4427681A Expired / Lapsed US ⏱️ 0.0 years remaining

Thixotropic compositions easily convertible to pourable liquids

Assignee: Richardson Vicks Inc
•
Filing: 1982-09-16
•
Granted: 1984-01-24
•
Expires: 2002-09-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compositions employing titanium dioxide as an opacifying agent and which are thixotropic gels easily convertible to pourable liquids with moderate shaking are provided by employing Avicel® RC-591 as the suspending agent for the composition.

Inventors

  • 👤 Mayank V. Munshi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 18:56
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0087; A61K9/0095; A61K47/00; A61K47/02; A61K47/30; A61K47/36; A61K47/38

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 69 words
An aqueous vehicle composition comprising water and (a) from about 1% to about 3% weight/volume of a suspendeding agent consisting of about 89% weight microcrystalline cellulose gel blended with about 11 weight percent sodium carboxymethylcellulose, and (b) from about 0.01% to about 0.5% weight/volume titanium dioxide, which composition is a thixotropic gel on standing but is easily convertable to a pourable liquid upon moderate shaking for about five seconds.
Claim 2
Dependent Claim 69 words
An aqueous vehicle composition comprising water and (a) from about 1% to about 3% weight/volume of a suspendeding agent consisting of about 89% weight microcrystalline cellulose gel blended with about 11 weight percent sodium carboxymethylcellulose, and (b) from about 0.01% to about 0.5% weight/volume titanium dioxide, which composition is a thixotropic gel on standing but is easily convertable to a pourable liquid upon moderate shaking for about five seconds.
Claim 3
Dependent Claim 39 words
A composition of claim 1 wherein the suspending agent is present in an amount of from about 1% to about 2% weight/volume and the titanium dioxide is present in an amount of from about 0.025% to about 0.1% weight/volume.
Claim 4
Dependent Claim 31 words
A composition of claim 2 wherein the suspending agent is present in an amount of about 11/2% weight/volume and the titanium dioxide is present in an amount of about 0.1% weight/volume.
Claim 5
Dependent Claim 43 words
A composition of claim 1 having a viscosity upon standing measured at 25° C. of from about 6,000 to about 8,000 cps and, after moderate shaking for about five seconds, a viscosity at 25° C. of from about 300 to about 800 cps.
Claim 6
Dependent Claim 43 words
A composition of claim 2 having a viscosity upon standing measured at 25° C. of from about 6,000 to about 8,000 cps and, after moderate shaking for about five seconds, a viscosity at 25° C. of from about 300 to about 800 cps.
Claim 7
Dependent Claim 43 words
A composition of claim 3 having a viscosity upon standing measured at 25° C. of from about 6,000 to about 8,000 cps and, after moderate shaking for about five seconds, a viscosity at 25° C. of from about 300 to about 800 cps.
Claim 8
Dependent Claim 12 words
A composition of claim 1 which is a cough/sore throat liquid composition.
Claim 9
Dependent Claim 12 words
A composition of claim 1 which is a throat coating cough medicine.
Claim 10
Dependent Claim 85 words
A composition of claim 1 comprising the following composition. ______________________________________ Ingredients Amount/15 ml Dose ______________________________________ Dextromethorphan HBr 15.0 mg Acetaminophen 650.0 mg Sugar 15.3 g Microcrystalline Cellulose and 375.0 mg Sodium CMC (Avicel ® RC-591, FMC) Sodium Citrate, Hydrous 156.6 mg Citric Acid, Anhydrous 101.4 mg Sodium Benzoate 30.0 mg Sorbitol Solution 600.0 mg Glycerine 600.0 mg Titanium dioxide 30.0 mg Propylene Glycol 3.6 g Alcohol, 95% (abs) 3.0 ml Flavorant 10.35 mg Menthol 36.0 mg Colorant 0.72 mg Water, Purified, q.s. 30.0 ml ______________________________________
Claim 11
Dependent Claim 81 words
A composition of claim 1 comprising the following composition: ______________________________________ Ingredients Amount/15 ml Dose ______________________________________ Guaifenesin 200.0 mg Sugar 7.65 g Microcrystalline Cellulose and 187.5 mg Sodium CMC (Avicel ® RC-591, FMC) Sodium Citrate, Hydrous 78.3 mg Citric Acid, Anhydrous 50.7 mg Sodium Benzoate 15.0 mg Sorbitol Solution 300.0 mg Glycerin 300.0 mg Titanium dioxide 15.0 mg Propylene Glycol 1.8 g Alcohol, 95% (abs) 1.5 ml Flavorants 15.0 μl Menthol 12.0 mg Colorants 3.75 mg Water, Purified, q.s. 15.0 ml. ______________________________________
Claim 12
Dependent Claim 89 words
A composition of claim 1 comprising the following composition: ______________________________________ Ingredients Amount/30 ml Dose ______________________________________ Dextromethorpham HBr 10.0 mg Acetaminophen 480.0 mg Sugar 15.3 g Microcrystalline Cellulose and 375.0 mg Sodium CMC (Avicel ® RC-591, FMC) Sodium Citrate, Hydrous 156.6 mg Citric Acid, Anhydrous 101.4 mg Sodium Benzoate 30.0 mg Sodium Saccharin 12.0 mg Sorbitol Solution 600.0 mg Glycerin 600.0 mg Titanium dioxide 30.0 mg Propylene Glycol 4.5 g Alcohol, 95% (abs) 2.25 ml Flavorant 0.0375 ml Menthol 12.0 mg Colorant 0.60 mg Water, Purified, q.s. 30.0 ml. ______________________________________
Claim 13
Dependent Claim 82 words
A composition of claim 1 comprising the following composition: ______________________________________ Ingredients Amount/15 ml Dose ______________________________________ Dextromethorphan HBr 30.0 mg Sugar 7.65 g Microcrystalline Cellulose and 187.5 mg Sodium CMC (Avicel ® RC-591, FMC) Sodium Citrate, Hydrous 78.3 mg Citric Acid, Anhydrous 50.7 mg Sodium Benzoate 15.0 mg Sorbitol Solution 300.0 mg Glycerin 300.0 mg Titanium dioxide 15.0 mg Propylene Glycol 1.8 g Alcohol, 95% (abs) 1.5 ml Flavorant 37.5 μl Menthol 12.0 mg Colorant 3.0 mg Water, Purified, q.s. 15.0 ml. ______________________________________
Claim 14
Dependent Claim 89 words
A composition of claim 1 comprising the following composition: ______________________________________ Ingredients Amount/15 ml Dose ______________________________________ Guaifenesin 200.0 mg Phenylpropanolamine HCl 37.5 mg Dextromethorphan HBr 20.0 mg Sugar 7.65 g Microcrystalline Cellulose and 187.5 mg Sodium CMC (Avicel ® RC-591, FMC) Sodium Citrate, Hydrous 300.0 mg Citric Acid, Anhydrous 3.5 mg Sodium Benzoate 15.0 mg Sorbitol Solution 300.0 mg Glycerin 300.0 mg Titanium dioxide 15.0 mg Propylene Glycol 1.8 g Alcohol, 95% (abs) 1.5 ml Flavorant 15.0 μl Menthol 12.0 mg Colorants 1.53 mg Water, Purified, q.s. 15.0 ml. ______________________________________
Claim 15
Dependent Claim 90 words
A composition of claim 1 comprising the following composition: ______________________________________ Ingredients Amount/15 ml Dose ______________________________________ Phenylpropanolamine HCl 37.5 mg Dextromethorphan HBr 20.0 mg Doxylamine Succinate 7.5 mg Sugar 7.65 g Microcrystalline Cellulose and 187.5 mg Sodium CMC (Avicel ® RC-591, FMC) Sodium Citrate, Hydrous 300.0 mg Citric Acid, Anhydrous 3.5 mg Sodium Benzoate 15.0 mg Sorbitol Solution 300.0 mg Glycerin 300.0 mg Titanium dioxide 15.0 mg Propylene Glycol 1.8 g Alcohol, 95% (abs) 1.5 ml Flavorant 37.5 μl Menthol 12.0 mg Colorant 0.3 mg Water, Purified, q.s. 15.0 ml. ______________________________________
Claim 16
Dependent Claim 86 words
A composition of claim 1 comprising the following composition: ______________________________________ Ingredients Amount/15 ml Dose ______________________________________ Dextromethorphan HBr 15.0 mg Doxylamine Succinate 7.5 mg Sugar 7.65 g Microcrystalline Cellulose and 187.5 mg Sodium CMC (Avicel ® RC-591, FMC) Sodium Citrate, Hydrous 78.3 mg Citric Acid, Anhydrous 15.0 mg Sodium Benzoate 15.0 mg Sorbitol Solution 300.0 mg Glycerin 300.0 mg Titanium dioxide 15.0 mg Propylene Glycol 2.25 g Alcohol, 95% (abs) 1.5 ml Menthol 11.25 mg Flavorants 8.0 mg Colorant 0.054 mg Water, Purified, q.s. 15.0 ml. ______________________________________
Claim 17
Dependent Claim 89 words
A composition of claim 1 comprising the following composition: ______________________________________ Ingredients Amount/15 ml Dose ______________________________________ Guaifenesin 200.0 mg Phenylpropanolamine HCl 25.0 mg Dextromethorphan HBr 20.0 mg Microcrystalline Cellulose and 187.5 mg Sodium CMC (Avicel ® RC-591, FMC) Sodium Citrate, Hydrous 300.0 mg Citric Acid, Anhydrous 3.5 mg Sodium Benzoate 15.0 mg Sorbitol Solution 300.0 mg Glycerin 300.0 mg Titanium dioxide 15.0 mg Propylene Glycol 2.25 g Alcohol, 95% (abs) 1.5 ml Flavorant 25.5 μl Menthol 18.0 mg Colorant 3.0 mg Sugar 10.2 g Water, Purified, q.s. 15.0 ml. ______________________________________

References Cited (Backward Citations)

US3134720A Cited
US3927205A Cited
US4284649A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-01-23 1987-07-25 1988-01-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-01-23 1991-07-25 1992-01-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-01-23 1995-07-25 1996-01-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag